73 related articles for article (PubMed ID: 10851564)
1. The effects of a low-dose regimen of fosinopril on elevated urinary albumin excretion in normotensive type 1 diabetic patients.
Carella MJ; Gossain VV; Jones J
J Med; 1999; 30(5-6):305-20. PubMed ID: 10851564
[TBL] [Abstract][Full Text] [Related]
2. Plasma matrix metalloproteinase-9 and ACE-inhibitor-induced improvement of urinary albumin excretion in non-diabetic, microalbuminuric subjects.
van de Wal RM; van der Harst P; Gerritsen WB; van der Horst F; Plokker TH; Gansevoort RT; van Gilst WH; Voors AA
J Renin Angiotensin Aldosterone Syst; 2007 Dec; 8(4):177-80. PubMed ID: 18205096
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiency.
Tong PC; Ko GT; Chan WB; Ma RC; So WY; Lo MK; Lee KF; Ozaki R; Chow CC; Cockram CS; Chan JC
Diabetes Obes Metab; 2006 May; 8(3):342-7. PubMed ID: 16634995
[TBL] [Abstract][Full Text] [Related]
4. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.
Asselbergs FW; Diercks GF; Hillege HL; van Boven AJ; Janssen WM; Voors AA; de Zeeuw D; de Jong PE; van Veldhuisen DJ; van Gilst WH;
Circulation; 2004 Nov; 110(18):2809-16. PubMed ID: 15492322
[TBL] [Abstract][Full Text] [Related]
5. Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes.
Estacio RO; Coll JR; Tran ZV; Schrier RW
Am J Hypertens; 2006 Dec; 19(12):1241-8. PubMed ID: 17161769
[TBL] [Abstract][Full Text] [Related]
6. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
[TBL] [Abstract][Full Text] [Related]
7. Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria.
Heerspink HL; Greene T; Lewis JB; Raz I; Rohde RD; Hunsicker LG; Schwartz SL; Aronoff S; Katz MA; Eisner GM; Mersey JH; Wiegmann TB;
Nephrol Dial Transplant; 2008 Jun; 23(6):1946-54. PubMed ID: 18089623
[TBL] [Abstract][Full Text] [Related]
8. ACE inhibitor intervention in Type 1 diabetes with low grade microalbuminuria.
Poulsen PL
J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):17-26. PubMed ID: 12692749
[TBL] [Abstract][Full Text] [Related]
9. Factors determining the 24-h blood pressure profile in normotensive patients with type 1 and type 2 diabetes.
Spallone V; Maiello MR; Cicconetti E; Pannone A; Barini A; Gambardella S; Menzinger G
J Hum Hypertens; 2001 Apr; 15(4):239-46. PubMed ID: 11319671
[TBL] [Abstract][Full Text] [Related]
10. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
[TBL] [Abstract][Full Text] [Related]
11. High normo- or low microalbuminuria: basis for intervention in insulin-dependent diabetes mellitus.
Poulsen PL; Ebbehøj E; Hansen KW; Mogensen CE
Kidney Int Suppl; 1997 Dec; 63():S15-8. PubMed ID: 9407413
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT).
Atthobari J; Asselbergs FW; Boersma C; de Vries R; Hillege HL; van Gilst WH; Gansevoort RT; de Jong PE; de Jong-van den Berg LT; Postma MJ;
Clin Ther; 2006 Mar; 28(3):432-44. PubMed ID: 16750458
[TBL] [Abstract][Full Text] [Related]
13. Determinants of urinary albumin excretion reduction in essential hypertension: A long-term follow-up study.
Pascual JM; Rodilla E; Miralles A; Gonzalez C; Redon J
J Hypertens; 2006 Nov; 24(11):2277-84. PubMed ID: 17053551
[TBL] [Abstract][Full Text] [Related]
14. The bedtime administration of doxazosin controls morning hypertension and albuminuria in patients with type-2 diabetes: evaluation using home-based blood pressure measurements.
Kamoi K; Ikarashi T
Clin Exp Hypertens; 2005 May; 27(4):369-76. PubMed ID: 15921073
[TBL] [Abstract][Full Text] [Related]
15. The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study.
Atthobari J; Brantsma AH; Gansevoort RT; Visser ST; Asselbergs FW; van Gilst WH; de Jong PE; de Jong-van den Berg LT;
Nephrol Dial Transplant; 2006 Nov; 21(11):3106-14. PubMed ID: 16720593
[TBL] [Abstract][Full Text] [Related]
16. [Pulse wave velocity and urinary albumin excretion in hypertensive patients treated with perindopril].
Toblli JE; Bellido CA; Iavícoli OR; Costa M; Forcada P; Piñeiro DJ; Lerman J
Medicina (B Aires); 2002; 62(6):544-50. PubMed ID: 12532688
[TBL] [Abstract][Full Text] [Related]
17. Predictors of angiotensin-converting enzyme inhibitor-induced reduction of urinary albumin excretion in nondiabetic patients.
van de Wal RM; Gansevoort RT; van der Harst P; Boomsma F; Thijs Plokker HW; van Veldhuisen DJ; de Jong PE; van Gilst WH; Voors AA
Hypertension; 2006 Nov; 48(5):870-6. PubMed ID: 17000930
[TBL] [Abstract][Full Text] [Related]
18. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
Agha A; Bashir K; Anwar E
Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953
[TBL] [Abstract][Full Text] [Related]
19. Effect of combination therapy with a calcium channel blocker and an angiotensin-converting enzyme inhibitor on renal hypertrophy and urinary albumin excretion in diabetic rats.
Nielsen B; Grønbaek H; Osterby R; Flyvbjerg A
Exp Diabesity Res; 2003; 4(3):191-9. PubMed ID: 15061647
[TBL] [Abstract][Full Text] [Related]
20. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
